Prucalopride Versus Placebo in Diabetic Gastroparesis: Randomized Placebo-controlled Crossover Trial
Latest Information Update: 02 Dec 2021
At a glance
- Drugs Prucalopride (Primary)
- Indications Diabetic gastroparesis
- Focus Proof of concept; Therapeutic Use
- Sponsors Janssen Inc
- 01 Nov 2018 Status changed from recruiting to completed.
- 18 Aug 2016 Planned End Date changed from 1 Dec 2016 to 1 Dec 2018.
- 18 Aug 2016 Planned primary completion date changed from 1 Sep 2016 to 1 Jun 2018.